BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join

All Posts


Biopharma Financial Climate and Market Dynamics …

Biopharma Financial Climate and Market Dynamics in 2023: Interview with David Dowling, Ropes & Gray

March 1, 2023   by Andrii Buvailo     Interviews
Recently, David Dowling, a senior lawyer at Ropes & Gray, has outlined his predictions for M&A in the European biotech …
Continue ›››
The Time for Breakthroughs in Antibiotic …

The Time for Breakthroughs in Antibiotic Discovery

Feb. 4, 2023   by Andrii Buvailo     --
Since a revolutionary discovery of penicillin in 1928 by Scottish bacteriologist and Nobel laureate Alexander Fleming, numerous inventions of new …
Continue ›››
British Patient Capital Backs Notable Cancer …

British Patient Capital Backs Notable Cancer Research with $7 million Investment in Grey Wolf Therapeutics

Jan. 26, 2023   by Andrii Buvailo     News
British Patient Capital, a subsidiary of the British Business Bank, invested $7 million in Grey Wolf Therapeutics, an Oxford-based biotech …
Continue ›››
Unlocking the Proteome's Secrets: The Advancement …

Unlocking the Proteome's Secrets: The Advancement of Single-Molecule Protein Sequencing Techniques

Jan. 25, 2023   by Andrii Buvailo     --
Even though characterizing the proteome, the complete set of proteins made by a cell or organism, can yield important insights …
Continue ›››
Democratizing Early Drug Discovery through Artificial …

Democratizing Early Drug Discovery through Artificial Intelligence: Interview with Syntekabio CEO Jongsun Jung

Jan. 17, 2023   by Sabina Lee     Interviews
Sponsored by Syntekabio
Before the age of modern drug discovery, the pharmaceutical industry had been plagued with uncertainty and processing challenges, including the …
Continue ›››
2022 in Retrospect: 10 Breakthrough Technologies …

2022 in Retrospect: 10 Breakthrough Technologies in Drug Discovery

Jan. 5, 2023   by Andrii Buvailo     --
Reflecting on 2022, let’s review several breakthrough technologies that are shaping the future of biology research and drug discovery. I …
Continue ›››
15 Biopharma Research Trends to Watch …

15 Biopharma Research Trends to Watch in 2022

Dec. 29, 2022   by Andrii Buvailo     --
Table of contents:    mRNA vaccines and RNA therapies  Epitranscriptomics Targeting RNA with small molecules Deep learning and big data …
Continue ›››
A Look at Longevity Industry: Interview …

A Look at Longevity Industry: Interview with Dr. Eric Leire, CEO of Genflow Biosciences

Dec. 28, 2022   by Andrii Buvailo     Interviews
The aging research industry has exploded in recent years. Once a fringe area of science, aging research has now gained …
Continue ›››
Innovation and Sustainability Trends for 2023: …

Innovation and Sustainability Trends for 2023: Interview with Jesper Jonsson, Director of Medical Devices at Owen Mumford

Dec. 22, 2022   by Andrii Buvailo     Interviews
The medical device industry is driven by constant innovation, and the annual Medica conference offers the chance to discover the …
Continue ›››
14 Publicly Traded Companies Developing Longevity …

14 Publicly Traded Companies Developing Longevity Therapeutics

Dec. 19, 2022   by BiopharmaTrend     --
The longevity industry has been growing throughout the past decades, attracting more attention to the healthy aging process and searching …
Continue ›››
Choosing Cancer Weapons With the Best …

Choosing Cancer Weapons With the Best Aim

Dec. 15, 2022   by Basem Goueli MD/PhD/MBA     --
In oncology, we do the best we can. We give drugs with 10-20% chances of working because we have nothing …
Continue ›››
MGI Tech Expands Sequencing Capabilities in …

MGI Tech Expands Sequencing Capabilities in Europe

Dec. 12, 2022   by Bohdana Sokolova     --
In November, MGI Tech Co, a Shenzhen-based biotechnology company, an affiliated company of BGI Group, committed to building core tools and …
Continue ›››
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.